These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature. Castro MP; VanAuken J; Spencer-Cisek P; Legha S; Sponzo RW Cancer; 1999 Mar; 85(5):1055-9. PubMed ID: 10091788 [TBL] [Abstract][Full Text] [Related]
23. Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials. Seidemann K; Meyer U; Jansen P; Yakisan E; Rieske K; Führer M; Kremens B; Schrappe M; Reiter A Klin Padiatr; 1998; 210(4):279-84. PubMed ID: 9743966 [TBL] [Abstract][Full Text] [Related]
24. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. Häberle B; Bode U; von Schweinitz D Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356 [TBL] [Abstract][Full Text] [Related]
25. Acute tumor lysis syndrome with squamous cell carcinoma of the vulva. Shamseddine AI; Khalil AM; Wehbeh MH Gynecol Oncol; 1993 Nov; 51(2):258-60. PubMed ID: 8276304 [TBL] [Abstract][Full Text] [Related]
27. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787 [TBL] [Abstract][Full Text] [Related]
28. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach. Hsu HH; Chan YL; Huang CC J Nephrol; 2004; 17(1):50-6. PubMed ID: 15151259 [TBL] [Abstract][Full Text] [Related]
29. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948 [TBL] [Abstract][Full Text] [Related]
30. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system. Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848 [TBL] [Abstract][Full Text] [Related]
31. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors. Choi LM; Rood B; Kamani N; La Fond D; Packer RJ; Santi MR; Macdonald TJ Pediatr Blood Cancer; 2008 May; 50(5):970-5. PubMed ID: 17941070 [TBL] [Abstract][Full Text] [Related]
32. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Kalemkerian GP; Darwish B; Varterasian ML Am J Med; 1997 Nov; 103(5):363-7. PubMed ID: 9375703 [TBL] [Abstract][Full Text] [Related]
33. Tumour lysis syndrome: new therapeutic strategies and classification. Cairo MS; Bishop M Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972 [TBL] [Abstract][Full Text] [Related]
34. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature. Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296 [TBL] [Abstract][Full Text] [Related]
35. A case of tumor lysis syndrome following chemotherapy for a uterine epithelioid leiomyosarcoma with focal rhabdomyosarcomatous differentiation. Hiraizumi Y; Kamoi S; Inde Y; Kurose K; Ohaki Y; Takeshita T J Obstet Gynaecol Res; 2011 Jul; 37(7):947-52. PubMed ID: 21410837 [TBL] [Abstract][Full Text] [Related]
36. [Tumor lysis syndrome. A life-threatening complication during cytostatic treatment of chemosensitive types of cancer]. Wibe E; Kvaløy S; Nome O; Abrahamsen AF; Bjørgo S Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2435-7. PubMed ID: 1926084 [TBL] [Abstract][Full Text] [Related]
37. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Davidson MB; Thakkar S; Hix JK; Bhandarkar ND; Wong A; Schreiber MJ Am J Med; 2004 Apr; 116(8):546-54. PubMed ID: 15063817 [TBL] [Abstract][Full Text] [Related]
38. [Rasburicase versus allopurinol in the treatment of hyperuricaemia in tumour lysis syndrome]. Tatay VS; Castilla JD; Ponce JM; Hurtado JM; Cantero E; Abril ML An Pediatr (Barc); 2010 Feb; 72(2):103-10. PubMed ID: 20022572 [TBL] [Abstract][Full Text] [Related]
39. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T; J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523 [TBL] [Abstract][Full Text] [Related]
40. Clarifying the role of rasburicase in tumor lysis syndrome. Sood AR; Burry LD; Cheng DK Pharmacotherapy; 2007 Jan; 27(1):111-21. PubMed ID: 17192165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]